The FDA declined approval for odronextamab, a drug that was already approved in Europe.

The entities involved

• FDA →
  • The illegal U.S. vape market is estimated to be worth $9 billion, fueled by unauthorized imports from China, while products must meet FDA authorization standards.Sun 20:36
  • VDPHL01 and Veradermics, Incorporated are seeking FDA approval for their lead therapies targeting hair loss.Sun 20:31
• Regeneron Pharmaceuticals →

  American pharmaceutical company

  • Parabilis Medicines debuted on Nasdaq, achieving IPO haul surpassing Moderna's, while its product received FDA fast-track designation. Regeneron also acquired shares.Sat 13:46

Related events

• Arise is seeking FDA approval for a drug as of October 7, 2026.Oct 7
• Generic medicine services are seeking approval for launch from the FDA.Sep 28
• FDA approved a drug based on UVA research led by Xuemei Huang.Oct 13
• Both the FDA and the European Medicines Agency govern drug approval processes.Aug 12
• Inventiva seeks FDA approval for lanifibranor in the U.S. market.Sep 2